Inamed correction
This article was originally published in The Gray Sheet
Executive Summary
Inamed received an FDA "approvable" letter in September for the following breast implant models: Styles 10, 15, 20, 40, 45, 110, 115 and 120, after it removed Style 153 from the application (1"The Gray Sheet" Sept. 26, 2005, p. 17). An article in the Dec. 12 issue of "The Gray Sheet" incorrectly stated that Inamed had received an "approvable" letter for its Style 153 silicone breast implant (2"The Gray Sheet" Dec. 12, 2005, p. 8)...
You may also be interested in...
Former Mentor Employee Claims Firm Could Reduce Silicone Implant “Bleed”
A former engineer for Mentor says the company decided against upgrading its Memory Gel silicone breast implants with patches capable of decreasing silicone oil leaks, or "bleeds.
Inamed Receives Silicone Breast Implant “Approvable” Letter From FDA
Inamed's silicone gel-filled breast implants inched closer to the market with the receipt of an FDA "approvable" letter, after the firm removed the controversial Style 153 implants from its PMA application
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.